LIBATAPE PHARMACEUTICAL is the first manufacturer of the first-aid plasters in Japan.
Department of quality assurance guarantees the highest quality of the delivered product.
Meditec company is the distributor in the Republic of Kazakhstan from 2023. Hemostatic plasters have certificates of registration.
Biobase is a group of companies engaged in the development and production of laboratory, medical, and scientific equipment, instruments, and in vitro diagnostic (IVD) reagents.
The company’s products are widely used in biological and chemical laboratories, as well as in industrial processes with strict cleanliness requirements.
Since its establishment in 1999, BIOBASE has earned the trust of customers in more than 130 countries and has opened representative offices in the USA, Dubai, India, Algeria, and Singapore. Today, the company employs over 5,000 people and operates 22 manufacturing facilities with a total area of 932,900 m².
The Biobase portfolio includes
All BIOBASE products are certified in accordance with EU, ISO, CE, EN, NSF, and FDA standards and are covered by manufacturer warranty service.
Since 2020, Meditec has been a distributor of BIOBASE products, offering laboratory equipment with an optimal balance of price and quality.
Biosan company was founded in 1992 by Doctor of Biological Sciences Vasily Bankovsky and biochemist Svetlana Bankovska from the Institute of Microbiology of Latvian Academy of Sciences.
Biosan became joint Latvian and English enterprise from 2005 and set a goal to become global leader in the field of sample preparation and analytics in Life Science.
The main philosophy of the company is development of modern mini laboratories for sample preparation and diagnostics used in genomics, proteomics and cellomics. High-quality laboratory equipment (secondary). Distribution contract is valid from 2020.
Xi'an Tianlong Technology Co., Ltd is one of the leading Chinese manufacturers of equipment and reagents for investigations in the field of molecular biology. PCR diagnostic kits, kits for distinguishing nucleic acids, PCR-amplifiers and many others are presented in the company’s portfolio.
Tianlong cooperates with hospitals, clinical laboratories, centres of disease control, commercial organizations and universities more than in 80 countries.
Company won the National award of China in the field of science and technology in 2020 and from 2022 leads Chinese National program of investigations and projects of the 14th Five-Year Plan.
Quality management systems of Tianlong conform to international standards of ISO 13485 & 9001. Its products have 50 NMPA certificates (analogue of FDA in China) and more than 120 international certificates (CE, FDA and etc.).